Clara Bloomfield

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Anatomy

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Baldus Claudia D; Thibaut Julia; Goekbuget Nicola; Stroux Andrea; Schlee Cornelia; Mossner Max; Burmeister Thomas; Schwartz Stefan; Bloomfield Clara D; Hoelzer Dieter; Thiel Eckhard; Hofmann Wolf-Karsten
Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia.
Walter Matthew J; Payton Jacqueline E; Ries Rhonda E; Shannon William D; Deshmukh Hrishikesh; Zhao Yu; Baty Jack; Heath Sharon; Westervelt Peter; Watson Mark A; Tomasson Michael H; Nagarajan Rakesh; O'Gara Brian P; Bloomfield Clara D; Mrózek Krzysztof; Selzer Rebecca R; Richmond Todd A; Kitzman Jacob; Geoghegan Joel; Eis Peggy S; Maupin Rachel; Fulton Robert S; McLellan Michael; Wilson Richard K; Mardis Elaine R; Link Daniel C; Graubert Timothy A; DiPersio John F; Ley Timothy J
Acquired copy number alterations in adult acute myeloid leukemia genomes.
Langer Christian; Marcucci Guido; Holland Kelsi B; Radmacher Michael D; Maharry Kati; Paschka Peter; Whitman Susan P; Mrózek Krzysztof; Baldus Claudia D; Vij Ravi; Powell Bayard L; Carroll Andrew J; Kolitz Jonathan E; Caligiuri Michael A; Larson Richard A; Bloomfield Clara D
Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Clara Bloomfield (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Baldus Claudia D; Thibaut Julia; Goekbuget Nicola; Stroux Andrea; Schlee Cornelia; Mossner Max; Burmeister Thomas; Schwartz Stefan; Bloomfield Clara D; Hoelzer Dieter; Thiel Eckhard; Hofmann Wolf-Karsten
Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia.
Haematologica 2009;94(10):1383-90.
2009: Walter Matthew J; Payton Jacqueline E; Ries Rhonda E; Shannon William D; Deshmukh Hrishikesh; Zhao Yu; Baty Jack; Heath Sharon; Westervelt Peter; Watson Mark A; Tomasson Michael H; Nagarajan Rakesh; O'Gara Brian P; Bloomfield Clara D; Mrózek Krzysztof; Selzer Rebecca R; Richmond Todd A; Kitzman Jacob; Geoghegan Joel; Eis Peggy S; Maupin Rachel; Fulton Robert S; McLellan Michael; Wilson Richard K; Mardis Elaine R; Link Daniel C; Graubert Timothy A; DiPersio John F; Ley Timothy J
Acquired copy number alterations in adult acute myeloid leukemia genomes.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(31):12950-5.
2009: Langer Christian; Marcucci Guido; Holland Kelsi B; Radmacher Michael D; Maharry Kati; Paschka Peter; Whitman Susan P; Mrózek Krzysztof; Baldus Claudia D; Vij Ravi; Powell Bayard L; Carroll Andrew J; Kolitz Jonathan E; Caligiuri Michael A; Larson Richard A; Bloomfield Clara D
Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(19):3198-204.
2009: Vardiman James W; Thiele Jüergen; Arber Daniel A; Brunning Richard D; Borowitz Michael J; Porwit Anna; Harris Nancy Lee; Le Beau Michelle M; Hellström-Lindberg Eva; Tefferi Ayalew; Bloomfield Clara D
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.
Blood 2009;114(5):937-51.
2009: Marcucci Guido; Mrózek Krzysztof; Radmacher Michael D; Bloomfield Clara D; Croce Carlo M
MicroRNA expression profiling in acute myeloid and chronic lymphocytic leukaemias.
Best practice & research. Clinical haematology 2009;22(2):239-48.
2009: Garzon Ramiro; Liu Shujun; Fabbri Muller; Liu Zhongfa; Heaphy Catherine E A; Callegari Elisa; Schwind Sebastian; Pang Jiuxia; Yu Jianhua; Muthusamy Natarajan; Havelange Violaine; Volinia Stefano; Blum William; Rush Laura J; Perrotti Danilo; Andreeff Michael; Bloomfield Clara D; Byrd John C; Chan Kenneth; Wu Lai-Chu; Croce Carlo M; Marcucci Guido
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1.
Blood 2009;113(25):6411-8.
2009: Stone Richard M; Donohue Kathleen A; Stock Wendy; Hars Vera; Linker Charles A; Shea Thomas; Deangelo Daniel J; Marcucci Guido; Bloomfield Clara D; Larson Richard A;
A phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804.
Cancer chemotherapy and pharmacology 2009;63(5):859-64.
2009: Mrózek Krzysztof; Radmacher Michael D; Bloomfield Clara D; Marcucci Guido
Molecular signatures in acute myeloid leukemia.
Current opinion in hematology 2009;16(2):64-9.
2009: Grinblatt David L; Yu Daohai; Hars Vera; Vardiman James W; Powell Bayard L; Nattam Sreenivasa; Silverman Lewis R; de Castro Carlos; Stone Richard M; Bloomfield Clara D; Larson Richard A;
Treatment of myelodysplastic syndrome with 2 schedules and doses of oral topotecan: a randomized phase 2 trial by the Cancer and Leukemia Group B (CALGB 19803).
Cancer 2009;115(1):84-93.
2008: Mrózek Krzysztof; Marcucci Guido; Paschka Peter; Bloomfield Clara D
Advances in molecular genetics and treatment of core-binding factor acute myeloid leukemia.
Current opinion in oncology 2008;20(6):711-8.
2008: Marcucci Guido; Maharry Kati; Radmacher Michael D; Mrózek Krzysztof; Vukosavljevic Tamara; Paschka Peter; Whitman Susan P; Langer Christian; Baldus Claudia D; Liu Chang-Gong; Ruppert Amy S; Powell Bayard L; Carroll Andrew J; Caligiuri Michael A; Kolitz Jonathan E; Larson Richard A; Bloomfield Clara D
Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(31):5078-87.
2008: Metzeler Klaus H; Hummel Manuela; Bloomfield Clara D; Spiekermann Karsten; Braess Jan; Sauerland Maria-Cristina; Heinecke Achim; Radmacher Michael; Marcucci Guido; Whitman Susan P; Maharry Kati; Paschka Peter; Larson Richard A; Berdel Wolfgang E; Büchner Thomas; Wörmann Bernhard; Mansmann Ulrich; Hiddemann Wolfgang; Bohlander Stefan K; Buske Christian;
An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia.
Blood 2008;112(10):4193-201.
2008: Greenberg Peter L; Attar Eyal; Battiwalla Minoo; Bennett John M; Bloomfield Clara D; DeCastro Carlos M; Deeg H Joachim; Erba Harry P; Foran James M; Garcia-Manero Guillermo; Gore Steven D; Head David; Maness Lori J; Millenson Michael; Nimer Stephen D; O'Donnell Margaret R; Saba Hussain I; Shami Paul J; Spiers Kathy; Stone Richard M; Tallman Martin S; Westervelt Peter;
Myelodysplastic syndromes.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(9):902-26.
2008: Baer Maria R; George Stephen L; Caligiuri Michael A; Sanford Ben L; Bothun Sandra M; Mrózek Krzysztof; Kolitz Jonathan E; Powell Bayard L; Moore Joseph O; Stone Richard M; Anastasi John; Bloomfield Clara D; Larson Richard A
Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(30):4934-9.
2008: Neubauer Andreas; Maharry Kati; Mrózek Krzysztof; Thiede Christian; Marcucci Guido; Paschka Peter; Mayer Robert J; Larson Richard A; Liu Edison T; Bloomfield Clara D
Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(28):4603-9.
2008: Paschka Peter; Marcucci Guido; Ruppert Amy S; Whitman Susan P; Mrózek Krzysztof; Maharry Kati; Langer Christian; Baldus Claudia D; Zhao Weiqiang; Powell Bayard L; Baer Maria R; Carroll Andrew J; Caligiuri Michael A; Kolitz Jonathan E; Larson Richard A; Bloomfield Clara D
Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(28):4595-602.
2008: Whitman Susan P; Hackanson Björn; Liyanarachchi Sandya; Liu Shujun; Rush Laura J; Maharry Kati; Margeson Dean; Davuluri Ramana; Wen Jing; Witte Tatiana; Yu Li; Liu Chunhui; Bloomfield Clara D; Marcucci Guido; Plass Christoph; Caligiuri Michael A
DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication.
Blood 2008;112(5):2013-6.
2008: Stock Wendy; La Mei; Sanford Ben; Bloomfield Clara D; Vardiman James W; Gaynon Paul; Larson Richard A; Nachman James;
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies.
Blood 2008;112(5):1646-54.
2008: Bloomfield Clara D; Marcucci Guido; Döhner Konstanze; Döhner Hartmut
Acute myeloid leukemia. Introduction.
Seminars in oncology 2008;35(4):324-5.
2008: Mrózek Krzysztof; Carroll Andrew J; Maharry Kati; Rao Kathleen W; Patil Shivanand R; Pettenati Mark J; Watson Michael S; Arthur Diane C; Tantravahi Ramana; Heerema Nyla A; Koduru Prasad R K; Block Annemarie W; Qumsiyeh Mazin B; Edwards Colin G; Sterling Lisa J; Holland Kelsi B; Bloomfield Clara D
Central review of cytogenetics is necessary for cooperative group correlative and clinical studies of adult acute leukemia: the Cancer and Leukemia Group B experience.
International journal of oncology 2008;33(2):239-44.
2008: Hoppe Richard T; Advani Ranjana Hira; Ambinder Richard F; Bierman Philip J; Bloomfield Clara D; Blum Kristie; Dabaja Bouthaina; Djulbegovic Benjamin; Forero Andres; Gordon Leo I; Hernandez-Ilizaliturri Francisco J; Hudson Melissa M; Kaminski Mark S; Love Gena; Maloney David G; Mansur David; Mauch Peter M; Moore Joseph O; Schilder Russell J; Weiss Lawrence M; Winter Jane N; Yahalom Joachim; Zelenetz Andrew D;
Hodgkin disease/lymphoma.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(6):594-622.
2008: Wetzler Meir; Donohue Kathleen A; Odenike Olatoyosi M; Feldman Eric J; Hurd David D; Stone Richard M; Westerfelt Peter; Bloomfield Clara D; Larson Richard A
Feasibility of administering oblimersen (G3139; Genasense) with imatinib mesylate in patients with imatinib resistant chronic myeloid leukemia--Cancer and leukemia group B study 10107.
Leukemia & lymphoma 2008;49(7):1274-8.
2008: Langer Christian; Radmacher Michael D; Ruppert Amy S; Whitman Susan P; Paschka Peter; Mrózek Krzysztof; Baldus Claudia D; Vukosavljevic Tamara; Liu Chang-Gong; Ross Mary E; Powell Bayard L; de la Chapelle Albert; Kolitz Jonathan E; Larson Richard A; Marcucci Guido; Bloomfield Clara D;
High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study.
Blood 2008;111(11):5371-9.
2008: Hackanson Björn; Bennett Kristi L; Brena Romulo M; Jiang Jinmai; Claus Rainer; Chen Shih-Shih; Blagitko-Dorfs Nadya; Maharry Katie; Whitman Susan P; Schmittgen Thomas D; Lübbert Michael; Marcucci Guido; Bloomfield Clara D; Plass Christoph
Epigenetic modification of CCAAT/enhancer binding protein alpha expression in acute myeloid leukemia.
Cancer research 2008;68(9):3142-51.
2008: Marcucci Guido; Radmacher Michael D; Maharry Kati; Mrózek Krzysztof; Ruppert Amy S; Paschka Peter; Vukosavljevic Tamara; Whitman Susan P; Baldus Claudia D; Langer Christian; Liu Chang-Gong; Carroll Andrew J; Powell Bayard L; Garzon Ramiro; Croce Carlo M; Kolitz Jonathan E; Caligiuri Michael A; Larson Richard A; Bloomfield Clara D
MicroRNA expression in cytogenetically normal acute myeloid leukemia.
The New England journal of medicine 2008;358(18):1919-28.
2008: Tomasson Michael H; Xiang Zhifu; Walgren Richard; Zhao Yu; Kasai Yumi; Miner Tracie; Ries Rhonda E; Lubman Olga; Fremont Daved H; McLellan Michael D; Payton Jacqueline E; Westervelt Peter; DiPersio John F; Link Daniel C; Walter Matthew J; Graubert Timothy A; Watson Mark; Baty Jack; Heath Sharon; Shannon William D; Nagarajan Rakesh; Bloomfield Clara D; Mardis Elaine R; Wilson Richard K; Ley Timothy J
Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia.
Blood 2008;111(9):4797-808.
2008: Garzon Ramiro; Volinia Stefano; Liu Chang-Gong; Fernandez-Cymering Cecilia; Palumbo Tiziana; Pichiorri Flavia; Fabbri Muller; Coombes Kevin; Alder Hansjuerg; Nakamura Tatsuya; Flomenberg Neal; Marcucci Guido; Calin George A; Kornblau Steven M; Kantarjian Hagop; Bloomfield Clara D; Andreeff Michael; Croce Carlo M
MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia.
Blood 2008;111(6):3183-9.
2008: Whitman Susan P; Ruppert Amy S; Radmacher Michael D; Mrózek Krzysztof; Paschka Peter; Langer Christian; Baldus Claudia D; Wen Jing; Racke Frederick; Powell Bayard L; Kolitz Jonathan E; Larson Richard A; Caligiuri Michael A; Marcucci Guido; Bloomfield Clara D
FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications.
Blood 2008;111(3):1552-9.
2008: Mrózek Krzysztof; Bloomfield Clara D
Clinical significance of the most common chromosome translocations in adult acute myeloid leukemia.
Journal of the National Cancer Institute. Monographs 2008;(39):52-7.
2008: Ferketich Amy K; Katz Mira L; Kauffman Ross M; Paskett Electra D; Lemeshow Stanley; Westman Judith A; Clinton Steven K; Bloomfield Clara D; Wewers Mary Ellen
Tobacco use among the Amish in Holmes County, Ohio.
The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association 2008;24(1):84-90.
2007: Neviani Paolo; Santhanam Ramasamy; Oaks Joshua J; Eiring Anna M; Notari Mario; Blaser Bradley W; Liu Shujun; Trotta Rossana; Muthusamy Natarajan; Gambacorti-Passerini Carlo; Druker Brian J; Cortes Jorge; Marcucci Guido; Chen Ching-Shih; Verrills Nicole M; Roy Denis C; Caligiuri Michael A; Bloomfield Clara D; Byrd John C; Perrotti Danilo
FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.
The Journal of clinical investigation 2007;117(9):2408-21.
2007: Link Daniel C; Kunter Ghada; Kasai Yumi; Zhao Yu; Miner Tracie; McLellan Michael D; Ries Rhonda E; Kapur Deepak; Nagarajan Rakesh; Dale David C; Bolyard Audrey Anna; Boxer Laurence A; Welte Karl; Zeidler Cornelia; Donadieu Jean; Bellanné-Chantelot Christine; Vardiman James W; Caligiuri Michael A; Bloomfield Clara D; DiPersio John F; Tomasson Michael H; Graubert Timothy A; Westervelt Peter; Watson Mark; Shannon William; Baty Jack; Mardis Elaine R; Wilson Richard K; Ley Timothy J
Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia.
Blood 2007;110(5):1648-55.
2007: Baldus Claudia D; Martus Peter; Burmeister Thomas; Schwartz Stefan; Gökbuget Nicola; Bloomfield Clara D; Hoelzer Dieter; Thiel Eckhard; Hofmann Wolf K
Low ERG and BAALC expression identifies a new subgroup of adult acute T-lymphoblastic leukemia with a highly favorable outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(24):3739-45.
2007: Marcucci Guido; Maharry Kati; Whitman Susan P; Vukosavljevic Tamara; Paschka Peter; Langer Christian; Mrózek Krzysztof; Baldus Claudia D; Carroll Andrew J; Powell Bayard L; Kolitz Jonathan E; Larson Richard A; Bloomfield Clara D;
High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(22):3337-43.
2007: Tefferi Ayalew; Thiele Juergen; Orazi Attilio; Kvasnicka Hans Michael; Barbui Tiziano; Hanson Curtis A; Barosi Giovanni; Verstovsek Srdan; Birgegard Gunnar; Mesa Ruben; Reilly John T; Gisslinger Heinz; Vannucchi Alessandro M; Cervantes Francisco; Finazzi Guido; Hoffman Ronald; Gilliland D Gary; Bloomfield Clara D; Vardiman James W
Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel.
Blood 2007;110(4):1092-7.
2007: Caligiuri Michael A; Briesewitz Roger; Yu Jianhua; Wang Lisheng; Wei Min; Arnoczky Kristy J; Marburger Trent B; Wen Jing; Perrotti Danilo; Bloomfield Clara D; Whitman Susan P
Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia.
Blood 2007;110(3):1022-4.
2007: Baldus Claudia D; Mrózek Krzysztof; Marcucci Guido; Bloomfield Clara D
Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review.
British journal of haematology 2007;137(5):387-400.
2007: Whitman Susan P; Ruppert Amy S; Marcucci Guido; Mrózek Krzysztof; Paschka Peter; Langer Christian; Baldus Claudia D; Wen Jing; Vukosavljevic Tamara; Powell Bayard L; Carroll Andrew J; Kolitz Jonathan E; Larson Richard A; Caligiuri Michael A; Bloomfield Clara D
Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B study.
Blood 2007;109(12):5164-7.
2007: Wetzler Meir; Sanford Ben L; Kurtzberg Joanne; DeOliveira Divino; Frankel Stanley R; Powell Bayard L; Kolitz Jonathan E; Bloomfield Clara D; Larson Richard A
Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511.
Blood 2007;109(10):4164-7.
2007: Mrózek Krzysztof; Döhner Hartmut; Bloomfield Clara D
Influence of new molecular prognostic markers in patients with karyotypically normal acute myeloid leukemia: recent advances.
Current opinion in hematology 2007;14(2):106-14.
2007: Liu Ting Xi; Becker Michael W; Jelinek Jaroslav; Wu Wen-Shu; Deng Min; Mikhalkevich Natallia; Hsu Karl; Bloomfield Clara D; Stone Richard M; DeAngelo Daniel J; Galinsky Ilene A; Issa Jean-Pierre; Clarke Michael F; Look A Thomas
Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
Nature medicine 2007;13(1):78-83.
2007: Mrózek Krzysztof; Marcucci Guido; Paschka Peter; Whitman Susan P; Bloomfield Clara D
Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?
Blood 2007;109(2):431-48.
2006: Baldus Claudia D; Burmeister Thomas; Martus Peter; Schwartz Stefan; Gökbuget Nicola; Bloomfield Clara D; Hoelzer Dieter; Thiel Eckhard; Hofmann Wolf K
High expression of the ETS transcription factor ERG predicts adverse outcome in acute T-lymphoblastic leukemia in adults.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(29):4714-20.
2006: Radmacher Michael D; Marcucci Guido; Ruppert Amy S; Mrózek Krzysztof; Whitman Susan P; Vardiman James W; Paschka Peter; Vukosavljevic Tamara; Baldus Claudia D; Kolitz Jonathan E; Caligiuri Michael A; Larson Richard A; Bloomfield Clara D;
Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B study.
Blood 2006;108(5):1677-83.
2006: Paschka Peter; Marcucci Guido; Ruppert Amy S; Mrózek Krzysztof; Chen Hankui; Kittles Rick A; Vukosavljevic Tamara; Perrotti Danilo; Vardiman James W; Carroll Andrew J; Kolitz Jonathan E; Larson Richard A; Bloomfield Clara D;
Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(24):3904-11.
2006: Farag Sherif S; Archer Kellie J; Mrózek Krzysztof; Ruppert Amy S; Carroll Andrew J; Vardiman James W; Pettenati Mark J; Baer Maria R; Qumsiyeh Mazin B; Koduru Prasad R; Ning Yi; Mayer Robert J; Stone Richard M; Larson Richard A; Bloomfield Clara D
Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.
Blood 2006;108(1):63-73.
2006: Bloomfield Clara D; Mrózek Krzysztof; Caligiuri Michael A
Cancer and leukemia group B leukemia correlative science committee: major accomplishments and future directions.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(11 Pt 2):3564s-71s.
2006: Stock Wendy; Yu Daohai; Karrison Ted; Sher Dorie; Stone Richard M; Larson Richard A; Bloomfield Clara D
Quantitative real-time RT-PCR monitoring of BCR-ABL in chronic myelogenous leukemia shows lack of agreement in blood and bone marrow samples.
International journal of oncology 2006;28(5):1099-103.
2006: Garzon Ramiro; Pichiorri Flavia; Palumbo Tiziana; Iuliano Rodolfo; Cimmino Amelia; Aqeilan Rami; Volinia Stefano; Bhatt Darshna; Alder Hansjuerg; Marcucci Guido; Calin George A; Liu Chang-Gong; Bloomfield Clara D; Andreeff Michael; Croce Carlo M
MicroRNA fingerprints during human megakaryocytopoiesis.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(13):5078-83.
2006: Hoppe Richard T; Advani Ranjana Hira; Bierman Philip J; Bloomfield Clara D; Buadi Francis; Djulgegovic Benjamin; Forero Andres; Gordon Leo I; Hernandez-Ilizaliturri Francisco J; Kaminski Mark S; Love Gena; Maloney David G; Mauch Peter M; Moore Joseph O; Schilder Russell J; Weiss Lawrence; Winter Jane N; Yahalom Joachim; Zelenetz Andrew D;
Hodgkin disease/lymphoma. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(3):210-30.
2006: Baldus Claudia D; Thiede Christian; Soucek Silke; Bloomfield Clara D; Thiel Eckhard; Ehninger Gerhard
BAALC expression and FLT3 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics: prognostic implications.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(5):790-7.
2006: Greenberg Peter L; Baer Maria R; Bennett John M; Bloomfield Clara D; De Castro Carlos M; Deeg H Joachim; Devetten Marcel P; Emanuel Peter D; Erba Harry P; Estey Eli; Foran James; Gore Steven D; Millenson Michael; Navarro Willlis H; Nimer Stephen D; O'Donnell Margaret R; Saba Hussain I; Spiers Kathy; Stone Richard M; Tallman Martin S
Myelodysplastic syndromes clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(1):58-77.
2006: Mrózek Krzysztof; Bloomfield Clara D
Chromosome aberrations, gene mutations and expression changes, and prognosis in adult acute myeloid leukemia.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2006;():169-77.
2005: Marcucci Guido; Baldus Claudia D; Ruppert Amy S; Radmacher Michael D; Mrózek Krzysztof; Whitman Susan P; Kolitz Jonathan E; Edwards Colin G; Vardiman James W; Powell Bayard L; Baer Maria R; Moore Joseph O; Perrotti Danilo; Caligiuri Michael A; Carroll Andrew J; Larson Richard A; de la Chapelle Albert; Bloomfield Clara D
Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(36):9234-42.
2005: Neviani Paolo; Santhanam Ramasamy; Trotta Rossana; Notari Mario; Blaser Bradley W; Liu Shujun; Mao Hsiaoyin; Chang Ji Suk; Galietta Annamaria; Uttam Ashwin; Roy Denis C; Valtieri Mauro; Bruner-Klisovic Rebecca; Caligiuri Michael A; Bloomfield Clara D; Marcucci Guido; Perrotti Danilo
The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein.
Cancer cell 2005;8(5):355-68.
2005: Marcucci Guido; Mrózek Krzysztof; Ruppert Amy S; Maharry Kati; Kolitz Jonathan E; Moore Joseph O; Mayer Robert J; Pettenati Mark J; Powell Bayard L; Edwards Colin G; Sterling Lisa J; Vardiman James W; Schiffer Charles A; Carroll Andrew J; Larson Richard A; Bloomfield Clara D
Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5705-17.
2005: Whitman Susan P; Liu Shujun; Vukosavljevic Tamara; Rush Laura J; Yu Li; Liu Chunhui; Klisovic Marko I; Maharry Kati; Guimond Martin; Strout Matthew P; Becknell Brian; Dorrance Adrienne; Klisovic Rebecca B; Plass Christoph; Bloomfield Clara D; Marcucci Guido; Caligiuri Michael A
The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy.
Blood 2005;106(1):345-52.
2005: Marcucci Guido; Stock Wendy; Dai Guowei; Klisovic Rebecca B; Liu Shujun; Klisovic Marko I; Blum William; Kefauver Cheryl; Sher Dorie A; Green Margaret; Moran Mollie; Maharry Kati; Novick Steven; Bloomfield Clara D; Zwiebel James A; Larson Richard A; Grever Michael R; Chan Kenneth K; Byrd John C
Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(15):3404-11.
2005: Moore Joseph O; George Stephen L; Dodge Richard K; Amrein Philip C; Powell Bayard L; Kolitz Jonathan E; Baer Maria R; Davey Frederick R; Bloomfield Clara D; Larson Richard A; Schiffer Charles A
Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222.
Blood 2005;105(9):3420-7.
2005: Fröhling Stefan; Schlenk Richard F; Krauter Jürgen; Thiede Christian; Ehninger Gerhard; Haase Detlef; Harder Lana; Kreitmeier Sylvia; Scholl Claudia; Caligiuri Michael A; Bloomfield Clara D; Döhner Hartmut; Döhner Konstanze
Acute myeloid leukemia with deletion 9q within a noncomplex karyotype is associated with CEBPA loss-of-function mutations.
Genes, chromosomes & cancer 2005;42(4):427-32.
2005: Marcucci Guido; Mrózek Krzysztof; Bloomfield Clara D
Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogenetics.
Current opinion in hematology 2005;12(1):68-75.
2005: Farag Sherif S; Ruppert Amy S; Mrózek Krzysztof; Mayer Robert J; Stone Richard M; Carroll Andrew J; Powell Bayard L; Moore Joseph O; Pettenati Mark J; Koduru Prasad R K; Stamberg Judith; Baer Maria R; Block Annemarie W; Vardiman James W; Kolitz Jonathan E; Schiffer Charles A; Larson Richard A; Bloomfield Clara D
Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(3):482-93.
2004: Kolitz Jonathan E; George Stephen L; Dodge Richard K; Hurd David D; Powell Bayard L; Allen Steven L; Velez-Garcia Enrique; Moore Joseph O; Shea Thomas C; Hoke Eva; Caligiuri Michael A; Vardiman James W; Bloomfield Clara D; Larson Richard A;
Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(21):4290-301.
2004: Blum William; Mrózek Krzysztof; Ruppert Amy S; Carroll Andrew J; Rao Kathleen W; Pettenati Mark J; Anastasi John; Larson Richard A; Bloomfield Clara D
Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): results from Cancer and Leukemia Group B Study 8461 and review of the literature.
Cancer 2004;101(6):1420-7.
2004: Farag Sherif S; Ruppert Amy S; Mrózek Krzysztof; Carroll Andrew J; Pettenati Mark J; Le Beau Michelle M; Peterson Bercedis L; Powell Bayard L; Ozer Howard; Silver Richard T; Larson Richard A; Bloomfield Clara D;
Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a Cancer and Leukemia Group B study.
International journal of oncology 2004;25(1):143-51.
2004: Marcucci Guido; Mrózek Krzysztof; Ruppert Amy S; Archer Kellie J; Pettenati Mark J; Heerema Nyla A; Carroll Andrew J; Koduru Prasad R K; Kolitz Jonathan E; Sterling Lisa J; Edwards Colin G; Anastasi John; Larson Richard A; Bloomfield Clara D
Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid leukemia: results from cancer and leukemia group B study 8461.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(12):2410-8.
2004: Mrózek Krzysztof; Heerema Nyla A; Bloomfield Clara D
Cytogenetics in acute leukemia.
Blood reviews 2004;18(2):115-36.
2004: Sekeres Mikkael A; Peterson Bercedis; Dodge Richard K; Mayer Robert J; Moore Joseph O; Lee Edward J; Kolitz Jonathan; Baer Maria R; Schiffer Charles A; Carroll Andrew J; Vardiman James W; Davey Frederick R; Bloomfield Clara D; Larson Richard A; Stone Richard M;
Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia.
Blood 2004;103(11):4036-42.
2004: Rizzieri David A; Johnson Jeffrey L; Niedzwiecki Donna; Lee Edward J; Vardiman James W; Powell Bayard L; Barcos Maurice; Bloomfield Clara D; Schiffer Charles A; Peterson Bruce A; Canellos George P; Larson Richard A
Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251.
Cancer 2004;100(7):1438-48.
2004: Byrd John C; Ruppert Amy S; Mrózek Krzysztof; Carroll Andrew J; Edwards Colin G; Arthur Diane C; Pettenati Mark J; Stamberg Judith; Koduru Prasad R K; Moore Joseph O; Mayer Robert J; Davey Frederick R; Larson Richard A; Bloomfield Clara D
Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): results from CALGB 8461.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(6):1087-94.
2004: Baldus Claudia D; Liyanarachchi Sandya; Mrózek Krzysztof; Auer Herbert; Tanner Stephan M; Guimond Martin; Ruppert Amy S; Mohamed Nehad; Davuluri Ramana V; Caligiuri Michael A; Bloomfield Clara D; de la Chapelle Albert
Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21: Amplification discloses overexpression of APP, ETS2, and ERG genes.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(11):3915-20.
2004: Ferrando Adolfo A; Neuberg Donna S; Dodge Richard K; Paietta Elisabeth; Larson Richard A; Wiernik Peter H; Rowe Jacob M; Caligiuri Michael A; Bloomfield Clara D; Look A Thomas
Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia.
Lancet 2004;363(9408):535-6.
2004: Wetzler Meir; Dodge Richard K; Mrózek Krzysztof; Stewart Carleton C; Carroll Andrew J; Tantravahi Ramana; Vardiman James W; Larson Richard A; Bloomfield Clara D
Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a study of the Cancer and Leukaemia Group B.
British journal of haematology 2004;124(3):275-88.
2004: Poppe Bruce; Vandesompele Jo; Schoch Claudia; Lindvall Charlotta; Mrozek Krzysztof; Bloomfield Clara D; Beverloo H Berna; Michaux Lucienne; Dastugue Nicole; Herens Christian; Yigit Nurten; De Paepe Anne; Hagemeijer Anne; Speleman Frank
Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies.
Blood 2004;103(1):229-35.
2004: Kolitz J E; George S L; Baer M R; Lee E J; Bloomfield C D; Larson R A;
P-glycoprotein (Pgp) modulation in untreated acute myeloid leukemia (AML): Cancer and Leukemia Group B (CALGB) trials in younger and older adults.
Annals of hematology 2004;83 Suppl 1():S103-4.
2004: Marcucci G; Stock W; Dai G; Klisovic M I; Maharry K; Shen T; Liu S; Sher D A; Lucas D; Zwiebel A; Larson R A; Caligiuri M A; Bloomfield C D; Chan K K; Grever M R; Byrd J C
G3139, a BCL-2 antisense oligo-nucleotide, in AML.
Annals of hematology 2004;83 Suppl 1():S93-4.
2004: Bloomfield C D; Ruppert A S; Mrózek K; Kolitz J E; Moore J O; Mayer R J; Edwards C G; Sterling L J; Vardiman J W; Carroll A J; Pettenati M J; Stamberg J; Byrd J C; Marcucci G; Larson R A;
Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461.
Annals of hematology 2004;83 Suppl 1():S84-5.
2003: Cheson Bruce D; Bennett John M; Kopecky Kenneth J; Büchner Thomas; Willman Cheryl L; Estey Elihu H; Schiffer Charles A; Doehner Hartmut; Tallman Martin S; Lister T Andrew; Lo-Coco Francesco; Willemze Roel; Biondi Andrea; Hiddemann Wolfgang; Larson Richard A; Löwenberg Bob; Sanz Miguel A; Head David R; Ohno Ryuzo; Bloomfield Clara D;
Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4642-9.
2003: Bloomfield Clara D
Genetics in the management of adult de novo AML.
Clinical advances in hematology & oncology : H&O 2003;1(11):640, 645-6.
2003: Ley Timothy J; Minx Patrick J; Walter Matthew J; Ries Rhonda E; Sun Hui; McLellan Michael; DiPersio John F; Link Daniel C; Tomasson Michael H; Graubert Timothy A; McLeod Howard; Khoury Hanna; Watson Mark; Shannon William; Trinkaus Kathryn; Heath Sharon; Vardiman James W; Caligiuri Michael A; Bloomfield Clara D; Milbrandt Jeffrey D; Mardis Elaine R; Wilson Richard K
A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomes.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(24):14275-80.
2003: Baldus Claudia D; Tanner Stephan M; Kusewitt Donna F; Liyanarachchi Sandya; Choi Changsun; Caligiuri Michael A; Bloomfield Clara D; de la Chapelle Albert
BAALC, a novel marker of human hematopoietic progenitor cells.
Experimental hematology 2003;31(11):1051-6.
2003: Mrózek Krzysztof; Tanner Stephan M; Heinonen Kristiina; Bloomfield Clara D
Molecular cytogenetic characterization of the KG-1 and KG-1a acute myeloid leukemia cell lines by use of spectral karyotyping and fluorescence in situ hybridization.
Genes, chromosomes & cancer 2003;38(3):249-52.
2003: Marcucci Guido; Caligiuri Michael A; Bloomfield Clara D
Core binding factor (CBF) acute myeloid leukemia: is molecular monitoring by RT-PCR useful clinically?
European journal of haematology 2003;71(3):143-54.
2003: Baldus Claudia D; Tanner Stephan M; Ruppert Amy S; Whitman Susan P; Archer Kellie J; Marcucci Guido; Caligiuri Michael A; Carroll Andrew J; Vardiman James W; Powell Bayard L; Allen Steven L; Moore Joseph O; Larson Richard A; Kolitz Jonathan E; de la Chapelle Albert; Bloomfield Clara D
BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study.
Blood 2003;102(5):1613-8.
2003: Rauscher Garth H; Sandler Dale P; Poole Charles; Pankow James; Shore David; Bloomfield Clara D; Olshan Andrew F
Is family history of breast cancer a marker of susceptibility to exposures in the incidence of de novo adult acute leukemia?
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(4):289-94.
2003: Gallagher Robert E; Yeap Beow Y; Bi Wanli; Livak Kenneth J; Beaubier Nike; Rao Sreenivas; Bloomfield Clara D; Appelbaum Frederick R; Tallman Martin S; Slack James L; Willman Cheryl L
Quantitative real-time RT-PCR analysis of PML-RAR alpha mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129.
Blood 2003;101(7):2521-8.
2003: Szatrowski Ted P; Dodge Richard K; Reynolds Carol; Westbrook Carol A; Frankel Stanley R; Sklar Jeffrey; Stewart Carleton C; Hurd David D; Kolitz Jonathan E; Velez-Garcia Enrique; Stone Richard M; Bloomfield Clara D; Schiffer Charles A; Larson Richard A
Lineage specific treatment of adult patients with acute lymphoblastic leukemia in first remission with anti-B4-blocked ricin or high-dose cytarabine: Cancer and Leukemia Group B Study 9311.
Cancer 2003;97(6):1471-80.
2003: Silver Richard T; Peterson Bercedis L; Szatrowski Ted P; Powell Bayard L; Stock Wendy; Carroll Andrew J; Bloomfield Clara D; Schiffer Charles A; Larson Richard A
Treatment of the chronic phase of chronic myeloid leukemia with an intermittent schedule of recombinant interferon alfa-2b and cytarabine: results from CALGB study 9013.
Leukemia & lymphoma 2003;44(1):39-48.
2003: Peterson Bruce A; Petroni Gina R; Frizzera Glauco; Barcos Maurice; Bloomfield Clara D; Nissen Nis I; Hurd David D; Henderson Edward S; Sartiano George P; Johnson Jeffrey L; Holland James F; Gottlieb Arlan J
Prolonged single-agent versus combination chemotherapy in indolent follicular lymphomas: a study of the cancer and leukemia group B.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(1):5-15.
2003: Marcucci Guido; Byrd John C; Dai Guowei; Klisovic Marko I; Kourlas Peter J; Young Donn C; Cataland Spero R; Fisher Diane B; Lucas David; Chan Kenneth K; Porcu Pierluigi; Lin Zhong-Pin; Farag Sherif F; Frankel Stanley R; Zwiebel James A; Kraut Eric H; Balcerzak Stanley P; Bloomfield Clara D; Grever Michael R; Caligiuri Michael A
Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia.
Blood 2003;101(2):425-32.
2002: Byrd John C; Mrózek Krzysztof; Dodge Richard K; Carroll Andrew J; Edwards Colin G; Arthur Diane C; Pettenati Mark J; Patil Shivanand R; Rao Kathleen W; Watson Michael S; Koduru Prasad R K; Moore Joseph O; Stone Richard M; Mayer Robert J; Feldman Eric J; Davey Frederick R; Schiffer Charles A; Larson Richard A; Bloomfield Clara D;
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461).
Blood 2002;100(13):4325-36.
2002: Tallman Martin S; Andersen Janet W; Schiffer Charles A; Appelbaum Frederick R; Feusner James H; Woods William G; Ogden Angela; Weinstein Howard; Shepherd Lois; Willman Cheryl; Bloomfield Clara D; Rowe Jacob M; Wiernik Peter H
All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol.
Blood 2002;100(13):4298-302.
2002: Farag Sherif S; Archer Kellie J; Mrózek Krzysztof; Vardiman James W; Carroll Andrew J; Pettenati Mark J; Moore Joseph O; Kolitz Jonathan E; Mayer Robert J; Stone Richard M; Larson Richard A; Bloomfield Clara D
Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.
International journal of oncology 2002;21(5):1041-51.
2002: Farag Sherif S; George Stephen L; Lee Edward J; Baer Maria; Dodge Richard K; Becknell Brian; Fehniger Todd A; Silverman Lewis R; Crawford Jeffrey; Bloomfield Clara D; Larson Richard A; Schiffer Charles A; Caligiuri Michael A
Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B study 9420.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(9):2812-9.
2002: Rauscher Garth H; Sandler Dale P; Poole Charles; Pankow James; Mitchell Beverly; Bloomfield Clara D; Olshan Andrew F
Family history of cancer and incidence of acute leukemia in adults.
American journal of epidemiology 2002;156(6):517-26.
2002: Bloomfield Clara D
Clinical importance of genetic findings in adult AML.
International journal of hematology 2002;76 Suppl 2():176-7.
2002: Baer Maria R; George Stephen L; Dodge Richard K; O'Loughlin Kieran L; Minderman Hans; Caligiuri Michael A; Anastasi John; Powell Bayard L; Kolitz Jonathan E; Schiffer Charles A; Bloomfield Clara D; Larson Richard A
Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720.
Blood 2002;100(4):1224-32.
2002: Mrózek Krzysztof; Heinonen Kristiina; Theil Karl S; Bloomfield Clara D
Spectral karyotyping in patients with acute myeloid leukemia and a complex karyotype shows hidden aberrations, including recurrent overrepresentation of 21q, 11q, and 22q.
Genes, chromosomes & cancer 2002;34(2):137-53.
2002: Bloomfield Clara D; Archer Kellie J; Mrózek Krzysztof; Lillington Debra M; Kaneko Yasuhiko; Head David R; Dal Cin Paola; Raimondi Susana C
11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop.
Genes, chromosomes & cancer 2002;33(4):362-78.
2002: Rush Laura J; Heinonen Kristiina; Mrózek Krzysztof; Wolf Brian J; Abdel-Rahman Mohamed; Szymanska Jadwiga; Peltomäki Paivi; Kapadia Fehmida; Bloomfield Clara D; Caligiuri Michael A; Plass Christoph
Comprehensive cytogenetic and molecular genetic characterization of the TI-1 acute myeloid leukemia cell line reveals cross-contamination with K-562 cell line.
Blood 2002;99(5):1874-6.
2002: Slack James L; Waxman Samuel; Tricot Guido; Tallman Martin S; Bloomfield Clara D
Advances in the management of acute promyelocytic leukemia and other hematologic malignancies with arsenic trioxide.
The oncologist 2002;7 Suppl 1():1-13.
2001: Tanner S M; Austin J L; Leone G; Rush L J; Plass C; Heinonen K; Mrózek K; Sill H; Knuutila S; Kolitz J E; Archer K J; Caligiuri M A; Bloomfield C D; de La Chapelle A
BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(24):13901-6.
2001: Lee E J; Petroni G R; Schiffer C A; Freter C E; Johnson J L; Barcos M; Frizzera G; Bloomfield C D; Peterson B A
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(20):4014-22.
2001: Whitman S P; Archer K J; Feng L; Baldus C; Becknell B; Carlson B D; Carroll A J; Mrózek K; Vardiman J W; George S L; Kolitz J E; Larson R A; Bloomfield C D; Caligiuri M A
Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study.
Cancer research 2001;61(19):7233-9.
2001: Stone R M; Berg D T; George S L; Dodge R K; Paciucci P A; Schulman P P; Lee E J; Moore J O; Powell B L; Baer M R; Bloomfield C D; Schiffer C A
Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine.
Blood 2001;98(3):548-53.
2001: Marcucci G; Caligiuri M A; Döhner H; Archer K J; Schlenk R F; Döhner K; Maghraby E A; Bloomfield C D
Quantification of CBFbeta/MYH11 fusion transcript by real time RT-PCR in patients with INV(16) acute myeloid leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(7):1072-80.
2001: Baer M R; Stewart C C; Dodge R K; Leget G; Sulé N; Mrózek K; Schiffer C A; Powell B L; Kolitz J E; Moore J O; Stone R M; Davey F R; Carroll A J; Larson R A; Bloomfield C D
High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361).
Blood 2001;97(11):3574-80.
2001: Mrózek K; Iliszko M; Rys J; Babinska M; Niezabitowski A; Bloomfield C D; Limon J
Spectral karyotyping reveals 17;22 fusions in a cytogenetically atypical dermatofibrosarcoma protuberans with a large marker chromosome as a sole abnormality.
Genes, chromosomes & cancer 2001;31(2):182-6.
2001: Rush L J; Dai Z; Smiraglia D J; Gao X; Wright F A; Frühwald M; Costello J F; Held W A; Yu L; Krahe R; Kolitz J E; Bloomfield C D; Caligiuri M A; Plass C
Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 loci.
Blood 2001;97(10):3226-33.
2001: Mrózek K; Prior T W; Edwards C; Marcucci G; Carroll A J; Snyder P J; Koduru P R; Theil K S; Pettenati M J; Archer K J; Caligiuri M A; Vardiman J W; Kolitz J E; Larson R A; Bloomfield C D
Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(9):2482-92.
2001: Mrózek K; Heinonen K; Bloomfield C D
Clinical importance of cytogenetics in acute myeloid leukaemia.
Best practice & research. Clinical haematology 2001;14(1):19-47.
2001: Whitman S P; Strout M P; Marcucci G; Freud A G; Culley L L; Zeleznik-Le N J; Mrózek K; Theil K S; Kees U R; Bloomfield C D; Caligiuri M A
The partial nontandem duplication of the MLL (ALL1) gene is a novel rearrangement that generates three distinct fusion transcripts in B-cell acute lymphoblastic leukemia.
Cancer research 2001;61(1):59-63.
2001: Virtaneva K; Wright F A; Tanner S M; Yuan B; Lemon W J; Caligiuri M A; Bloomfield C D; de La Chapelle A; Krahe R
Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(3):1124-9.
2000: Mrózek K; Heinonen K; Bloomfield C D
Prognostic value of cytogenetic findings in adults with acute myeloid leukemia.
International journal of hematology 2000;72(3):261-71.
2000: Kourlas P J; Strout M P; Becknell B; Veronese M L; Croce C M; Theil K S; Krahe R; Ruutu T; Knuutila S; Bloomfield C D; Caligiuri M A
Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(5):2145-50.
2000: Slack J L; Willman C L; Andersen J W; Li Y P; Viswanatha D S; Bloomfield C D; Tallman M S; Gallagher R E
Molecular analysis and clinical outcome of adult APL patients with the type V PML-RARalpha isoform: results from intergroup protocol 0129.
Blood 2000;95(2):398-403.
1999: Byrd J C; Dodge R K; Carroll A; Baer M R; Edwards C; Stamberg J; Qumsiyeh M; Moore J O; Mayer R J; Davey F; Schiffer C A; Bloomfield C D
Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(12):3767-75.
1999: Strout M P; Marcucci G; Caligiuri M A; Bloomfield C D
Core-binding factor (CBF) and MLL-associated primary acute myeloid leukemia: biology and clinical implications.
Annals of hematology 1999;78(6):251-64.
1999: Wetzler M; Dodge R K; Mrózek K; Carroll A J; Tantravahi R; Block A W; Pettenati M J; Le Beau M M; Frankel S R; Stewart C C; Szatrowski T P; Schiffer C A; Larson R A; Bloomfield C D
Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience.
Blood 1999;93(11):3983-93.
1999: Czuczman M S; Dodge R K; Stewart C C; Frankel S R; Davey F R; Powell B L; Szatrowski T P; Schiffer C A; Larson R A; Bloomfield C D
Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B study 8364.
Blood 1999;93(11):3931-9.
1999: Plass C; Yu F; Yu L; Strout M P; El-Rifai W; Elonen E; Knuutila S; Marcucci G; Young D C; Held W A; Bloomfield C D; Caligiuri M A
Restriction landmark genome scanning for aberrant methylation in primary refractory and relapsed acute myeloid leukemia; involvement of the WIT-1 gene.
Oncogene 1999;18(20):3159-65.
1999: Vidal C; Baer M R; Bloomfield C D
Uncommon patterns of presentation of leukemia.
Hematological oncology 1999;17(1):11-29.
1998: Bloomfield C D; Lawrence D; Byrd J C; Carroll A; Pettenati M J; Tantravahi R; Patil S R; Davey F R; Berg D T; Schiffer C A; Arthur D C; Mayer R J
Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
Cancer research 1998;58(18):4173-9.
1998: Marcucci G; Livak K J; Bi W; Strout M P; Bloomfield C D; Caligiuri M A
Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12(9):1482-9.
1998: Larson R A; Dodge R K; Linker C A; Stone R M; Powell B L; Lee E J; Schulman P; Davey F R; Frankel S R; Bloomfield C D; George S L; Schiffer C A
A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111.
Blood 1998;92(5):1556-64.
1998: Wetzler M; Bernstein S H; Baumann H; Fries K M; Stewart C; Blumenson L; Baer M R; Herzig G P; Bloomfield C D; Slack J L
Expression and function of the megakaryocyte growth and development factor receptor in acute myeloid leukemia blasts.
Leukemia & lymphoma 1998;30(5-6):415-31.
1998: Heinonen K; Mrózek K; Lawrence D; Arthur D C; Pettenati M J; Stamberg J; Qumsiyeh M B; Verma R S; MacCallum J; Schiffer C A; Bloomfield C D
Clinical characteristics of patients with de novo acute myeloid leukaemia and isolated trisomy 11: a Cancer and Leukemia Group B study.
British journal of haematology 1998;101(3):513-20.
1998: Byrd J C; Lawrence D; Arthur D C; Pettenati M J; Tantravahi R; Qumsiyeh M; Stamberg J; Davey F R; Schiffer C A; Bloomfield C D
Patients with isolated trisomy 8 in acute myeloid leukemia are not cured with cytarabine-based chemotherapy: results from Cancer and Leukemia Group B 8461.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(5):1235-41.
1998: Baer M R; Stewart C C; Lawrence D; Arthur D C; Mrózek K; Strout M P; Davey F R; Schiffer C A; Bloomfield C D
Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12(3):317-25.
1998: Strout M P; Marcucci G; Bloomfield C D; Caligiuri M A
The partial tandem duplication of ALL1 (MLL) is consistently generated by Alu-mediated homologous recombination in acute myeloid leukemia.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(5):2390-5.
1998: Marcucci G; Strout M P; Bloomfield C D; Caligiuri M A
Detection of unique ALL1 (MLL) fusion transcripts in normal human bone marrow and blood: distinct origin of normal versus leukemic ALL1 fusion transcripts.
Cancer research 1998;58(4):790-3.
1998: Caligiuri M A; Strout M P; Lawrence D; Arthur D C; Baer M R; Yu F; Knuutila S; Mrózek K; Oberkircher A R; Marcucci G; de la Chapelle A; Elonen E; Block A W; Rao P N; Herzig G P; Powell B L; Ruutu T; Schiffer C A; Bloomfield C D
Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics.
Cancer research 1998;58(1):55-9.
1998: Elghetany M T; Peterson B; MacCallum J; Nelson D A; Varney J F; Sullivan A K; Silverman L R; Schiffer C A; Davey F R; Bloomfield C D
Double esterase staining and other neutrophilic granule abnormalities in 237 patients with the myelodysplastic syndrome studied by the cancer and leukemia group B.
Acta haematologica 1998;100(1):13-6.
1997: Bloomfield C D; Shuma C; Regal L; Philip P P; Hossfeld D K; Hagemeijer A M; Garson O M; Peterson B A; Sakurai M; Alimena G; Berger R; Rowley J D; Ruutu T; Mitelman F; Dewald G W; Swansbury J
Long-term survival of patients with acute myeloid leukemia: a third follow-up of the Fourth International Workshop on Chromosomes in Leukemia.
Cancer 1997;80(11 Suppl):2191-8.
1997: Bloomfield C D; Herzig G P; Peterson B A; Wolff S N
Long-term survival of patients with acute myeloid leukemia: updated results from two trials evaluating postinduction chemotherapy.
Cancer 1997;80(11 Suppl):2186-90.
1997: Marcucci G; Caligiuri M A; Bloomfield C D
Defining the "absence" of the CBFbeta/MYH11 fusion transcript in patients with acute myeloid leukemia and inversion of chromosome 16 to predict long-term complete remission: a call for definitions.
Blood 1997;90(12):5022-5024.
1997: Mrózek K; Heinonen K; Lawrence D; Carroll A J; Koduru P R; Rao K W; Strout M P; Hutchison R E; Moore J O; Mayer R J; Schiffer C A; Bloomfield C D
Adult patients with de novo acute myeloid leukemia and t(9; 11)(p22; q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B study.
Blood 1997;90(11):4532-8.
1997: Tallman M S; Andersen J W; Schiffer C A; Appelbaum F R; Feusner J H; Ogden A; Shepherd L; Willman C; Bloomfield C D; Rowe J M; Wiernik P H
All-trans-retinoic acid in acute promyelocytic leukemia.
The New England journal of medicine 1997;337(15):1021-8.
1997: Elghetany M T; Peterson B; MacCallum J; Nelson D A; Varney J F; Sullivan A K; Silverman L R; Schiffer C A; Davey F R; Bloomfield C D
Deficiency of neutrophilic granule membrane glycoproteins in the myelodysplastic syndromes: a common deficiency in 216 patients studied by the Cancer and Leukemia Group B.
Leukemia research 1997;21(9):801-6.
1997: Gallagher R E; Willman C L; Slack J L; Andersen J W; Li Y P; Viswanatha D; Bloomfield C D; Appelbaum F R; Schiffer C A; Tallman M S; Wiernik P H
Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular study.
Blood 1997;90(4):1656-63.
1997: Baer M R; Stewart C C; Lawrence D; Arthur D C; Byrd J C; Davey F R; Schiffer C A; Bloomfield C D
Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22).
Blood 1997;90(4):1643-8.
1997: Wetzler M; Baer M R; Bernstein S H; Blumenson L; Stewart C; Barcos M; Mrózek K; Block A W; Herzig G P; Bloomfield C D
Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2262-8.
1997: Slack J L; Arthur D C; Lawrence D; Mrózek K; Mayer R J; Davey F R; Tantravahi R; Pettenati M J; Bigner S; Carroll A J; Rao K W; Schiffer C A; Bloomfield C D
Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(5):1786-95.
1997: Caligiuri M A; Strout M P; Oberkircher A R; Yu F; de la Chapelle A; Bloomfield C D
The partial tandem duplication of ALL1 in acute myeloid leukemia with normal cytogenetics or trisomy 11 is restricted to one chromosome.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(8):3899-902.
1997: Byrd J C; Weiss R B; Arthur D C; Lawrence D; Baer M R; Davey F; Trikha E S; Carroll A J; Tantravahi R; Qumsiyeh M; Patil S R; Moore J O; Mayer R J; Schiffer C A; Bloomfield C D
Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):466-75.
1997: Mrózek K; Heinonen K; de la Chapelle A; Bloomfield C D
Clinical significance of cytogenetics in acute myeloid leukemia.
Seminars in oncology 1997;24(1):17-31.
1997: Stock W; Westbrook C A; Peterson B; Arthur D C; Szatrowski T P; Silver R T; Sher D A; Wu D; Le Beau M M; Schiffer C A; Bloomfield C D
Value of molecular monitoring during the treatment of chronic myeloid leukemia: a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(1):26-36.
1996: Bernstein S H; Brunetto V L; Davey F R; Wurster-Hill D; Mayer R J; Stone R M; Schiffer C A; Bloomfield C D
Acute myeloid leukemia-type chemotherapy for newly diagnosed patients without antecedent cytopenias having myelodysplastic syndrome as defined by French-American-British criteria: a Cancer and Leukemia Group B Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(9):2486-94.
1996: Jurlander J; Caligiuri M A; Ruutu T; Baer M R; Strout M P; Oberkircher A R; Hoffmann L; Ball E D; Frei-Lahr D A; Christiansen N P; Block A M; Knuutila S; Herzig G P; Bloomfield C D
Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia.
Blood 1996;88(6):2183-91.
1996: Heinonen K; Rao P N; Slack J L; Cruz J; Bloomfield C D; Mrózek K
Isochromosome 12p in two cases of acute myeloid leukaemia without evidence of germ cell tumour.
British journal of haematology 1996;93(3):677-80.
1996: Caligiuri M A; Strout M P; Schichman S A; Mrózek K; Arthur D C; Herzig G P; Baer M R; Schiffer C A; Heinonen K; Knuutila S; Nousiainen T; Ruutu T; Block A W; Schulman P; Pedersen-Bjergaard J; Croce C M; Bloomfield C D
Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11.
Cancer research 1996;56(6):1418-25.
1996: Baer M R; Bernstein S H; Brunetto V L; Heinonen K; Mrózek K; Swann V L; Minderman H; Block A W; Pixley L A; Christiansen N P; Fay J W; Barcos M; Rustum Y; Herzig G P; Bloomfield C D
Biological effects of recombinant human granulocyte colony-stimulating factor in patients with untreated acute myeloid leukemia.
Blood 1996;87(4):1484-94.
1995: Rai K R; Davey F; Peterson B; Schiffer C; Silver R T; Ozer H; Golomb H; Bloomfield C D
Recombinant alpha-2b-interferon in therapy of previously untreated hairy cell leukemia: long-term follow-up results of study by Cancer and Leukemia Group B.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(7):1116-20.
1994: Schichman S A; Caligiuri M A; Strout M P; Carter S L; Gu Y; Canaani E; Bloomfield C D; Croce C M
ALL-1 tandem duplication in acute myeloid leukemia with a normal karyotype involves homologous recombination between Alu elements.
Cancer research 1994;54(16):4277-80.
1994: Schichman S A; Caligiuri M A; Gu Y; Strout M P; Canaani E; Bloomfield C D; Croce C M
ALL-1 partial duplication in acute leukemia.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(13):6236-9.
1994: Mrózek K; Karakousis C P; Bloomfield C D
Band 11q13 is nonrandomly rearranged in hibernomas.
Genes, chromosomes & cancer 1994;9(2):145-7.
1994: Caligiuri M A; Schichman S A; Strout M P; Mrózek K; Baer M R; Frankel S R; Barcos M; Herzig G P; Croce C M; Bloomfield C D
Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations.
Cancer research 1994;54(2):370-3.
1993: Baer M R; Christiansen N P; Frankel S R; Brunetto V L; Mrózek K; Bloomfield C D; Herzig G P
High-dose cytarabine, idarubicin, and granulocyte colony-stimulating factor remission induction therapy for previously untreated de novo and secondary adult acute myeloid leukemia.
Seminars in oncology 1993;20(6 Suppl 8):6-12.
1993: Mrózek K; Bloomfield C D
Cytogenetics of indolent lymphomas.
Seminars in oncology 1993;20(5 Suppl 5):47-57.
1993: Mrózek K; Karakousis C P; Bloomfield C D
Chromosome 12 breakpoints are cytogenetically different in benign and malignant lipogenic tumors: localization of breakpoints in lipoma to 12q15 and in myxoid liposarcoma to 12q13.3.
Cancer research 1993;53(7):1670-5.
1993: Mrózek K; Karakousis C P; Perez-Mesa C; Bloomfield C D
Translocation t(12;22)(q13;q12.2-12.3) in a clear cell sarcoma of tendons and aponeuroses.
Genes, chromosomes & cancer 1993;6(4):249-52.
1993: Mir R; Anderson J; Strauchen J; Nissen N I; Cooper M R; Rafla S; Canellos G P; Bloomfield C D; Gottlieb A J; Peterson B
Hodgkin disease in patients 60 years of age or older. Histologic and clinical features of advanced-stage disease. The Cancer and Leukemia Group B.
Cancer 1993;71(5):1857-66.
1992: Westbrook C A; Hooberman A L; Spino C; Dodge R K; Larson R A; Davey F; Wurster-Hill D H; Sobol R E; Schiffer C; Bloomfield C D
Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762).
Blood 1992;80(12):2983-90.
1992: Bloomfield C D
Prognostic factors for selecting curative therapy for adult acute myeloid leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6 Suppl 4():65-7.
1992: Elghetany M T; Sullivan A K; Kurec A S; MacCallum J M; Bloomfield C D; Sobol R E; Davey F R
The use of monoclonal antibodies against primary myeloid granules in normal and leukemic cells.
American journal of clinical pathology 1992;98(4):430-6.
1992: Cimino G; Nakamura T; Gu Y; Canaani O; Prasad R; Crist W M; Carroll A J; Baer M; Bloomfield C D; Nowell P C
An altered 11-kilobase transcript in leukemic cell lines with the t(4;11)(q21;q23) chromosome translocation.
Cancer research 1992;52(13):3811-3.
1992: Baer M R; Bloomfield C D
Trisomy 13 in acute leukemia.
Leukemia & lymphoma 1992;7(1-2):1-6.
1992: Levine E G; Bloomfield C D
Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure.
Seminars in oncology 1992;19(1):47-84.
1992: Baer M R; Bloomfield C D
Cytogenetics and oncogenes in leukemia.
Current opinion in oncology 1992;4(1):24-32.
1991: Baer M R; Bloomfield C D
The clinical significance of biological characteristics of the cells in acute myeloid leukemia.
Annual review of medicine 1991;42():381-9.
1990: Gottlieb A J; Anderson J R; Ginsberg S J; Bloomfield C D; Norton L; Barcos M; Peterson B A; Nissen N; Henderson E S; Holland J F
A randomized comparison of methotrexate dose and the addition of bleomycin to CHOP therapy for diffuse large cell lymphoma and other non-Hodgkin's lymphomas. Cancer and Leukemia Group B study 7851.
Cancer 1990;66(9):1888-96.
1989: Davey F R; Davis R B; MacCallum J M; Nelson D A; Mayer R J; Ball E D; Griffin J D; Schiffer C A; Bloomfield C D
Morphologic and cytochemical characteristics of acute promyelocytic leukemia.
American journal of hematology 1989;30(4):221-7.
1988: Davey F R; Mick R; Nelson D A; MacCallum J; Sobol R E; Royston I; Cuttner J; Ellison R R; Bloomfield C D
Morphologic and cytochemical characterization of adult lymphoid leukemias which express myeloid antigen.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1988;2(7):420-6.
1987: Ginsberg S J; Anderson J R; Gottlieb A J; Bloomfield C D; Norton L; Barcos M; Holland J F
A randomized trial of high-dose methotrexate versus standard-dose methotrexate following cyclophosphamide, doxorubicin (adriamycin), vincristine, and prednisone with or without bleomycin in the therapy of diffuse large cell lymphoma: preliminary report of Cancer and Leukemia Group B Study 7851.
NCI monographs : a publication of the National Cancer Institute 1987;(5):77-80.
1986: Griffin J D; Davis R; Nelson D A; Davey F R; Mayer R J; Schiffer C; McIntyre O R; Bloomfield C D
Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemia.
Blood 1986;68(6):1232-41.
1985: Sobol R E; Royston I; LeBien T W; Minowada J; Anderson K; Davey F R; Cuttner J; Schiffer C; Ellison R R; Bloomfield C D
Adult acute lymphoblastic leukemia phenotypes defined by monoclonal antibodies.
Blood 1985;65(3):730-5.
1982: Peterson B A; Pajak T F; Cooper M R; Nissen N I; Glidewell O J; Holland J F; Bloomfield C D; Gottlieb A J
Effect of age on therapeutic response and survival in advanced Hodgkin's disease.
Cancer treatment reports 1982;66(4):889-98.
1982: Bloomfield C D; Pajak T F; Glicksman A S; Gottlieb A J; Coleman M; Nissen N I; Rafla S; Stutzman L; Vinciguerra V; Glidewell O J; Holland J F
Chemotherapy and combined modality therapy for Hodgkin's disease: a progress report on Cancer and Leukemia Group B studies.
Cancer treatment reports 1982;66(4):835-46.
1982: Ginsberg S J; Crooke S T; Bloomfield C D; Peterson B; Kennedy B J; Blom J; Ellison R R; Pajak T F; Gottlieb A J
Cyclophosphamide, doxorubicin, vincristine, and low-dose continuous infusion bleomycin in non-Hodgkin's lymphoma: Cancer and Leukemia Group B Study No. 7804.
Cancer 1982;49(7):1346-52.
1981: Rai K R; Holland J F; Glidewell O J; Weinberg V; Brunner K; Obrecht J P; Preisler H D; Nawabi I W; Prager D; Carey R W; Cooper M R; Haurani F; Hutchison J L; Silver R T; Falkson G; Wiernik P; Hoagland H C; Bloomfield C D; James G W; Gottlieb A; Ramanan S V; Blom J; Nissen N I; Bank A; Ellison R R; Kung F; Henry P; McIntyre O R; Kaan S K
Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B.
Blood 1981;58(6):1203-12.
1980: Nissen N I; Pajak T F; Leone L A; Bloomfield C D; Kennedy B J; Ellison R R; Silver R T; Weiss R B; Cuttner J; Falkson G; Kung F; Bergevin P R; Holland J F
Clinical trial of VP 16--213 (NSC 141540) I.V. twice weekly in advanced neoplastic disease: a study by the Cancer and Leukemia Group B.
Cancer 1980;45(2):232-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Clara Bloomfield

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Clara Bloomfield (preview)

All Publications